Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 329, pg 296, 2023)

被引：1
|
作者：
Mccarthy, M. W.
Naggie, S.
Boulware, D. R.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 330卷 / 16期
关键词：
D O I：
10.1001/jama.2023.20908
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1589 / 1589
页数：1
相关论文
共 50 条
  • [1] Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 A Randomized Clinical Trial
    McCarthy, Matthew W.
    Naggie, Susanna
    Boulware, David R.
    Lindsell, Christopher J.
    Stewart, Thomas G.
    Felker, G. Michael
    Jayaweera, Dushyantha
    Sulkowski, Mark
    Gentile, Nina
    Bramante, Carolyn
    Singh, Upinder
    Dolor, Rowena J.
    Ruiz-Unger, Juan
    Wilson, Sybil
    DeLong, Allison
    Remaly, April
    Wilder, Rhonda
    Collins, Sean
    Dunsmore, Sarah E.
    Adam, Stacey J.
    Thicklin, Florence
    Hanna, George
    Ginde, Adit A.
    Castro, Mario
    McTigue, Kathleen
    Shenkman, Elizabeth
    Hernandez, Adrian F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (04): : 296 - 305
  • [2] Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19 A Randomized Clinical Trial
    Naggie, Susanna
    Boulware, David R.
    Lindsell, Christopher J.
    Stewart, Thomas G.
    Gentile, Nina
    Collins, Sean
    McCarthy, Matthew William
    Jayaweera, Dushyantha
    Castro, Mario
    Sulkowski, Mark
    McTigue, Kathleen
    Thicklin, Florence
    Felker, G. Michael
    Ginde, Adit A.
    Bramante, Carolyn T.
    Slandzicki, Alex J.
    Gabriel, Ahab
    Shah, Nirav S.
    Lenert, Leslie A.
    Dunsmore, Sarah E.
    Adam, Stacey J.
    DeLong, Allison
    Hanna, George
    Remaly, April
    Wilder, Rhonda
    Wilson, Sybil
    Shenkman, Elizabeth
    Hernandez, Adrian F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (16): : 1595 - 1603
  • [3] Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19
    Ashraf, Sahar
    Ashraf, Nauman
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (19): : 1702 - 1702
  • [4] Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 328, pg 1595, 2022)
    Naggie, S.
    Boulware, D. R.
    Lindsell, C. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (02): : 178 - 178
  • [5] Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial (vol 329, pg 888, 2023)
    Naggie, S.
    Boulware, D. R.
    Lindsell, C. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (21): : 1867 - 1867
  • [6] Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
    Lenze, Eric J.
    Mattar, Caline
    Zorumski, Charles F.
    Stevens, Angela
    Schweiger, Julie
    Nicol, Ginger E.
    Miller, J. Philip
    Yang, Lei
    Yingling, Michael
    Avidan, Michael S.
    Reiersen, Angela M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (22): : 2292 - 2300
  • [7] In outpatients with mild to moderate COVID-19, low-dose fluvoxamine did not reduce time to sustained recovery
    Clark, Jeremy
    Tong, Steven Y. C.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (05) : JC52 - JC52
  • [8] Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19 A Randomized Clinical Trial
    Naggie, Susanna
    Boulware, David R.
    Lindsell, Christopher J.
    Stewart, Thomas G.
    Slandzicki, Alex J.
    Lim, Stephen C.
    Cohen, Jonathan
    Kavtaradze, David
    Amon, Arch P.
    Gabriel, Ahab
    Gentile, Nina
    Felker, G. Michael
    Jayaweera, Dushyantha
    McCarthy, Matthew W.
    Sulkowski, Mark
    Rothman, Russell L.
    Wilson, Sybil
    DeLong, Allison
    Remaly, April
    Wilder, Rhonda
    Collins, Sean
    Dunsmore, Sarah E.
    Adam, Stacey J.
    Thicklin, Florence
    Hanna, George J.
    Ginde, Adit A.
    Castro, Mario
    McTigue, Kathleen
    Shenkman, Elizabeth
    Hernandez, Adrian F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (11): : 888 - 897
  • [9] Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to ModerateCOVID-19:ARandomized Clinical Trial (vol 328, pg 1595, 2022)
    Naggie, S.
    Boulware, D. R.
    Lindsell, C. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (07): : 666 - 666
  • [10] Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19 The ACTIV-6 Randomized Clinical Trial
    Stewart, Thomas G.
    Rebolledo, Paulina A.
    Mourad, Ahmad
    Lindsell, Christopher J.
    Boulware, David R.
    McCarthy, Matthew W.
    Thicklin, Florence
    Del Sol, Idania T. Garcia
    Bramante, Carolyn T.
    Lenert, Leslie A.
    Lim, Stephen
    Williamson, John C.
    Cardona, Orlando Quintero
    Scott, Jake
    Schwasinger-Schmidt, Tiffany
    Ginde, Adit A.
    Castro, Mario
    Jayaweera, Dushyantha
    Sulkowski, Mark
    Gentile, Nina
    McTigue, Kathleen
    Felker, G. Michael
    DeLong, Allison
    Wilder, Rhonda
    Rothman, Russell L.
    Collins, Sean
    Dunsmore, Sarah E.
    Adam, Stacey J.
    Hanna, George J.
    Shenkman, Elizabeth
    Hernandez, Adrian F.
    Naggie, Susanna
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (24): : 2354 - 2363
12345